Skip to content

Price / sales at other companies

Amgen logo
AmgenAMGN
5.1×+0.2×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.5×+0.6×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
56.2×-26.1×
Immunome logo
ImmunomeIMNM
616.2×+563×
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
5.1×-0.1×
Incyte logo
IncyteINCY
3.5×+0.8×

Other financials

Income statement

See full
Revenue$10.9M+3.8%
Gross profit$21.8M+2.9%
Operating income-$39.1M+12.3%
Net income-$44.9M+11.7%
EPS (diluted)-$1.82+49.7%

Balance sheet

See full
Cash & equivalents$5.7M-20.0%
Total debt$83.2M-17.1%
Total equity$576.2M+4,094%
Total assets$763.3M+198%

Cash flow

See full
Operating cash flow-$44.3M+9.7%
CapEx$18.0K+800%
Free cash flow-$44.3M+9.7%

Valuation

See full
Market cap$2.25B+1,531%
Enterprise value$2.33B+874%

Profitability

See full
Gross margin100%+31.2pp
Operating margin-242%
Net margin-284.2%+937pp
FCF margin-366.6%+1,421pp

Returns & leverage

See full
Return on equity-53.6%-22.6pp
Debt / equity0.1×-7.2×
Current ratio10.2×+7.0×

Where this comes from

Calculated from Nektar Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nektar Therapeutics's price / sales?
Nektar Therapeutics (NKTR) reported price / sales of 37.1× in Q1 2026.
How has Nektar Therapeutics's price / sales changed year-over-year?
Nektar Therapeutics's price / sales increased by 2457.9% year-over-year, from 1.5× to 37.1×.
What is the long-term trend for Nektar Therapeutics's price / sales?
Over 5 years (2020 to 2025), Nektar Therapeutics's price / sales has grown at a -5.4% compound annual growth rate (CAGR), from 20.5× to 15.6×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.